Language： 简体中文 English
Your location： Home > Program
Print Program Outline Speakers
Query：
Date：
  • All
  • November 19, 2026
  • November 20, 2026
  • November 21, 2026
Hall：
  • All
  • 5th‑Floor Grand Ballroom
  • S101
  • S102
  • S103
  • S105
  • S106
  • S107
  • S109
  • S110
  • S111
  • S201
  • S202
  • S203
  • S204
  • S205
  • S206
  • S207
  • V11
  • V22
  • V23
  • V24
  • V25
  • InterContinental Ballroom 1
Subject：
  • All
  • Plenary Session
  • Oncology
  • Minimally Invasive Surgery
  • Stones
  • Incontinence
  • Robotic Surgery
  • Clinical Research
  • Basic and Translational Science
  • Female Urology
  • Andrology
  • Nursing
  • Infection
  • Renal Transplantation
  • Laser Surgery
  • Community Urology
  • Reconstructive Surgery
  • Adrenals
  • Pediatric Urology
  • Smart Surgery
  • Urological Engineering
  • Special Session
  • Prostate Cancer Pathfinders: Evidence into Action
  • Prostate Neoplasms Session
  • Benign Diseases Diagnosis & Treatment Session
  • Urolithiasis Standardized Care Project
  • Discovering Urological Frontiers
  • Urology & Prostate
  • Rising Leaders Urology
  • Urologic Oncology Session
  • Training Program for Urological Department
  • Precision Care in Urologic Oncology
  • Uro-Oncology Leadership & Innovation Forum
  • Remote Session: Normalized Surgical Practice
  • RCC Immunotherapy Session
  • Intelligent Leadership in Prostate Care
  • Bladder Cancer Session
  • MP + SP in URO Seminar
  • Benign Prostatic Hyperplasia Session
  • Ingenuity Exploration
  • Renal Cell Carcinoma Session
  • Prostate Cancer Session

November 19, 2026

S103

November 19, 2026 14:00-14:30 Part I: Opening Ceremony & Initial Data Presentation Prostate Neoplasms Session
Moderator ：
Jia Hu China
1 14:00-14:10

Opening Remarks

Xu Zhang China
Tianxin Lin China
Shaogang Wang China
2 14:10-14:20

Launch Ceremony of the CUA Prostate Cancer Abstract Reading Roadshow and the "Technique Meets Strategy" Series

Conference Congress Steering Committee China
3 14:20-14:30

Launch Ceremony: Aranote NRDL Inclusion and Release of DASL Clinical Trial Results

Moderator Hao Ceng China
Conference Congress Steering Committee China
November 19, 2026 14:00-14:30 Opening Remarks Prostate Neoplasms Session
1 14:00-14:30

Congress Chairpersons

Xu Zhang China
Tianxin Lin China
Shaogang Wang China
2 14:00-14:30

Congress Presidium

Jianbin Bi China
Xiaoming Cao China
Fan Cheng China
Bin Fu China
Weiyang He China
Bangmin Han China
Haowen Jiang China
Lei Li China
Xin Ma China
Weijun Qin China
Qiang Wei China
Benkang Shi China
Jianning Wang China
Tao Xu China
Wei Xue China
Dan Xia China
Danfeng Xu China
Xuepei Zhang China
Tie Chong China
Xiaoping Zhang China
November 19, 2026 14:30-16:20 Part II: Mutual Learning in Research & Lectures, Concerted Support Along the Whole Journey Prostate Neoplasms Session
November 19, 2026 14:30-15:30 Session 1: Exploring the Frontiers, Insights in Prostate Cancer Prostate Neoplasms Session
Moderator ：
Fan Cheng China 丨 Danfeng Xu China 丨 Jianming Guo China 丨 Sanxiang Li China 丨 Xuepei Zhang China
1 14:30-14:50

The Evolution of Prostate Cancer Surgery

Zhihua Wang China
2 14:50-15:00

Discussion

Xingang Cui China
Hai Huang China
Lu Sheng China
Yuan Li China
Yonghong Li China
Yinong Niu China
3 15:00-15:20

Advances in Novel Hormonal Therapy in the Perioperative Setting (Speaker-selected title)

Murphy Australia
4 15:20-15:30

Discussion

Zhiquan Hu China
Zan Liu China
Yang Liu China
Gaoliang Wu China
Bin Xu China
Xiongjun Ye China
November 19, 2026 15:30-16:00 Session 2: Digital-Intelligence Empowerment, Refined Quality Enhancement Prostate Neoplasms Session
Moderator ：
Bangmin Han China 丨 Xinquan Gu China 丨 Benkang Shi China
1 15:30-15:50

Conversion Therapy and CMI-related Topic

Jianwei Xuan China
2 15:50-16:00

Discussion

Bo Dai China
Jinming Di China
Zongyao Hao China
Peng Wu China
Wei Li China
Weimin Yu China
November 19, 2026 16:00-16:20 Session 3: Pursuit of Excellence, Expert Dialogue Prostate Neoplasms Session
Moderator ：
Bin Fu China 丨 Xiaoping Zhang China
1 16:00-16:20

Roundtable Discussion: Perioperative Treatment

Jiuzhi Li China
Mingyue Tan China
Li Xue China
Wei Xiong China
Xiaojian Yang China
November 19, 2026 16:20-18:10 Part III: Sino-foreign Integration, Evidence-based Conclusion Prostate Neoplasms Session
November 19, 2026 16:20-16:30 United in Effort for Two Years, Together We Open a New Chapter Prostate Neoplasms Session
Moderator ：
Jia Hu China
1 16:20-16:30

U-MBA Academy 2nd Anniversary Gala · Two Years, One Heart — United We Sail Far

November 19, 2026 16:30-17:00 Session I: Global Vision, Embarking on a New Chapter Prostate Neoplasms Session
Moderator ：
Baojun Wang China
1 16:30-16:45

Recent Advances in the Treatment of Prostate Cancer

Anuf Stezel Germany
2 16:45-17:00

Discussion

Chaohui Gu China
Yun Luo China
Haifeng Wang China
Simeng Wen China
Moderator Qingbo Huang China
Yi Zhu China
November 19, 2026 17:00-18:00 Session 2: China Voice from CUA Prostate Neoplasms Session
Moderator ：
Yong Wang China 丨 Wang He China 丨 Lu Yang China 丨 Di Gu China 丨 Mo Zhang China
1 17:00-17:05

CUA Prostate Cancer Abstract 1 Reading

Bao Zhang China
2 17:05-17:12

Discussion

Zhihong Dai China
Zhipeng Xu China
Zhipeng Xu China
3 17:12-17:17

CUA Prostate Cancer Abstract 2 Reading

Wenlong Zhong China
4 17:17-17:24

Discussion

Huimin Hou China
Qi Tang China
Theodoros Spinos Greece
5 17:24-17:29

Journal Club: Study Three

Bo Wu China
6 17:29-17:36

Discussion

Wenzhi Li China
Max Zirngibl Germany
Tao Tao China
Feiya Yang China
7 17:36-17:41

CUA Prostate Cancer Abstract 4 Reading

Yang Yu China
8 17:41-17:48

Discussion

Arianna Tumminello Italy
Bitian Liu China
Xuedong Wei China
9 17:48-18:00

Discussant

Xiaoming Cao China
Jianning Wang China
Wei Xue China
Dan Xia China
Weiyang He China
Tao Xu China
Jun Xiao China
November 19, 2026 17:50-18:20 Session 3 RWE in Review, Learning from the Past to Guide the Future Prostate Neoplasms Session
Moderator ：
Haowen Jiang China
1 18:00-18:15

RWE Study Design and Considerations

Deying Kang China
2 18:15-18:20

Summary

Jianbin Bi China